NovoCure Limited (NVCR) Stock Price

12.92 +0.00 (+0.00%)
Open: 12.99 Vol: 1.36M Day's range: 12.605 - 13.04 Sep 30, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
NVCR Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 12.82▲ 12.71▲ 12.72▲ 12.87▲ 12.59▲
MA10 12.77▲ 12.69▲ 12.79▲ 12.88▲ 12.19▲
MA20 12.70▲ 12.79▲ 12.83▲ 12.65▲ 14.61▼
MA50 12.68▲ 12.81▲ 12.88▲ 12.28▲ 18.76▼
MA100 12.77▲ 12.88▲ 12.77▲ 14.92▼ 17.45▼
MA200 12.83▲ 12.75▲ 12.44▲ 18.67▼ 41.40▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.025▲ 0.005▲ -0.005▼ 0.052▲ 0.089▲
RSI 80.459▲ 58.896▲ 55.529▲ 54.066▲ 38.982▼
STOCH 89.914▲ 33.560     22.256     50.891     38.679    
WILL %R 0.000▲ -26.744     -26.744     -39.427     -73.819    
CCI 176.251▲ 88.050     37.163     28.613     -21.176    
Latest Filters Detected On NVCR
MA $NVCR Price Crossed Above MA(7) Set Alert
CDL $NVCR Doji Candlestick Pattern Detected Set Alert
NovoCure Limited News
Novocure to Present Final Results from the Pivotal Phase 3 METIS Trial of its Tumor Treating Fields (TTFields) Therapy for Brain Metastases from Non-Small Cell Lung Cancer at ...
Monday, September 29, 2025 01:41 PM
Novocure (NASDAQ: NVCR) announced that final results from the Phase 3 METIS trial of Tumor Treating Fields (TTFields) therapy for brain metastases from non-small cell lung cancer (NSCLC) will be ...
Novocure's Optune Lua® Receives Approval in Japan for the Treatment of Unresectable Advanced/Recurrent Non-Small Cell Lung Cancer (NSCLC)
Monday, September 15, 2025 04:19 AM
Novocure (NASDAQ: NVCR) announced today that Japan's Ministry of Health, Labour and Welfare (MHLW) approved Optune Lua ® for concurrent use with PD-1/PD-L1 inhibitors for the treatment of adult ...
Novocure Announces Approval For Optune Lua In Japan
Monday, September 15, 2025 04:13 AM
(RTTNews) - Novocure (NVCR) announced that Japan's Ministry of Health, Labour and Welfare approved Optune Lua for concurrent use with PD-1/PD-L1 inhibitors for the treatment of adult patients with ...
NVCR historical stock data
date open high low close volume
30/09/25 12.99 13.04 12.605 12.92 1,361,617
29/09/25 12.91 13.01 12.72 12.92 1,117,166
26/09/25 12.91 13.00 12.7401 12.89 1,180,095
25/09/25 12.70 12.84 12.46 12.78 1,488,585
24/09/25 13.00 13.0985 12.69 12.84 1,410,474
23/09/25 13.04 13.47 12.94 13.00 1,363,539
22/09/25 12.70 13.40 12.55 13.09 2,681,117
19/09/25 13.06 13.10 12.54 12.69 2,169,416
18/09/25 12.77 13.11 12.67 13.00 1,421,542
17/09/25 12.70 13.24 12.53 12.69 1,417,698
Quote Details
52wk Low:10.87
52wk High:34.13
Vol:1.36M
Avg Vol(3m):34.2M
1Y Chng:-27.33%
1M Chng:+7.04%
Add to Watch List
More Information
Index US Composite
Market Cap. 1.44B